ft 08 feb 93 intern compani news sale growth slow amgen amgen share price plung friday us biotechnolog compani report slow sale growth pharmaceut product analyst cut estim futur earn net profit fourth quarter dollar 133 8m 91 cent per share howev includ one time pre tax arbitr award dollar 77 1m produc tax gain 34 cent per share amgen market right disput johnson amp johnson us healthcar product group period last year compani report net profit dollar 60m 41 cent share fourth quarter sale rose dollar 308 2m dollar 210m sale quarter epogen amgen anti anaemia drug dollar 135 7m slightli dollar 136 9m third quarter year sale increas dollar 506 3m dollar 409 4m 1991 sale neupogen receiv us market approv februari 1991 rose dollar 544 4m 1992 dollar 232 8m 1991 although fourth quarter earn line expect analyst express concern sale momentum slow compani share price close dollar 53 7 8 friday thursday dollar 59 3 4 year end decemb 31 total turnov dollar 1 1bn compar dollar 682m year earlier net profit came dollar 357 6m dollar 2 43 share compar dollar 97 9m 67 cent includ one time pre tax legal assess dollar 129 1m